Gain the Tools & Technological Roadmap to Advance Within the mHealth Space
The benefits that mHealth technology can offer clinical trials affect both those running them and those taking part. However, it remains unclear how operations can be capitalized. To help you solve these challenges, the 5th annual IMPACCT: mHealth in Clinical Trials Summit will provide you with a practical roadmap and the decision-making tools required to implement this plethora of technology into your clinical trials.
This meeting, which is free to attend for academics, drug developers, and researchers, will see the most important collaboration in the mHealth space yet and includes trial sponsors, technology experts, regulators, patients, and technology providers. For the 5th year, hear from and network with companies such as Pfizer, Takeda, AbbVie, The Michael J. Fox Foundation, Active Insights, CTTI as they narrate past experience and future insights such as:
|Managing Patient Adherence for Digital Devices - Aman Thukral, Head of Digital Operations e& eCOA, AbbVie|
|Keep on Walking: Progresses in Developing Digital Endpoints for Gait - Hao Zhang, Senior Manager, Biomedical Engineering, Pfizer|
|Waiter: This Data isn’t Raw Enough! Discussing the Trade-off Between Data Capture and Data Processing - Ariel Dowling, Director of Digital Strategy, Takeda|
|How to Collaborate for Collective Benefit - Rachel Chasse, Director of Innovation, Digital Medicine Society (DiMe) & Shyamal Patel, Director, Head of Data Science, Pfizer|
With exclusive case studies and the release of previously unpublished data, the IMPACCT: mHealth in Clinical Trials Summit is where the key stakeholders of the industry will transform the way patient data is collected and utilized, rethink clinical trial methodologies, overcome key implementation challenges and promote patient-centricity in clinical studies with mobile and digital approaches.